These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3140119)

  • 1. Does gastric acid secretion affect phosphate binding by aluminium phosphate binding gels in chronic renal failure?
    Cassidy M; Swanepoel C; Bridger S; Marks IN
    Nephrol Dial Transplant; 1988; 3(3):358. PubMed ID: 3140119
    [No Abstract]   [Full Text] [Related]  

  • 2. Aluminum and phosphate.
    Kaye M; Turner M; Ardila M; Wiegmann T; Hodsman A
    Kidney Int Suppl; 1988 Mar; 24():S172-4. PubMed ID: 3163042
    [No Abstract]   [Full Text] [Related]  

  • 3. The gastric secretion profile of patients with chronic renal failure.
    Ala-Kaila K; Kataja M; Keyriläinen O; Pasternack A
    Ann Clin Res; 1981 Apr; 13(2):65-70. PubMed ID: 7235612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aluminium accumulation in patients with chronic renal failure (author's transl)].
    Tsukamoto Y; Marumo F; Iwanami S; Nango H; Higashishiba H; Nakazawa R
    Nihon Jinzo Gakkai Shi; 1980 Jun; 22(6):721-8. PubMed ID: 7206332
    [No Abstract]   [Full Text] [Related]  

  • 5. A new approach to the evaluation of hyperphosphatemia in chronic kidney disease.
    Savica V; Calò LA; Granata A; Caldarera R; Cavaleri A; Santoro D; Monardo P; Savica R; Muraca U; Bellinghieri G
    Clin Nephrol; 2007 Oct; 68(4):216-21. PubMed ID: 17969488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Iatrogenic aluminum osteopathy in a uremic infant].
    Koch H; Reich H; Franke D; Delling G
    Monatsschr Kinderheilkd; 1986 May; 134(5):279-81. PubMed ID: 3724766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of phosphate in the jejunum of patients with chronic renal failure before and after correction of vitamin D deficiency.
    Davis GR; Zerwekh JE; Parker TF; Krejs GJ; Pak CY; Fordtran JS
    Gastroenterology; 1983 Oct; 85(4):908-16. PubMed ID: 6688402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal handling of calcium, magnesium and inorganic phosphate in chronic renal failure.
    Better OS; Kleeman CR; Gonick HC; Varrady PD; Maxwell MH
    Isr J Med Sci; 1967; 3(1):60-79. PubMed ID: 6047692
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum-aluminum in nondialyzed chronic uremic patients before and during treatment with aluminum-containing phosphate-binding gels.
    Brahm M
    Clin Nephrol; 1986 May; 25(5):231-5. PubMed ID: 3720033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Aluminum gels in chronic kidney failrue patients. A potential risk of encephalopathy and osteopathy].
    Rottembourg J; Jaudon MC; Legrain M; Galli A
    Ann Med Interne (Paris); 1980; 131(2):71-4. PubMed ID: 7396323
    [No Abstract]   [Full Text] [Related]  

  • 12. [Kinetics of aluminum absorption and serum concentration in chronic renal insufficiency].
    Sárszegi Z; Jobst K; Nagy J
    Orv Hetil; 2000 Aug; 141(35):1915-7. PubMed ID: 11019592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aluminum-balance during haemodialysis (author's transl)].
    Graf H; Stummvoll HK; Kovarik J; Meisinger V; Wolf A; Pinggera WF
    Wien Klin Wochenschr; 1980; 92(11):391-4. PubMed ID: 7424016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the parathyroid function, various biochemical parameters of calcium and phosphate metabolism and bone changes in chronic renal failure].
    Kontek M
    Pol Tyg Lek; 1980 Mar; 35(12):433-6. PubMed ID: 7383933
    [No Abstract]   [Full Text] [Related]  

  • 15. Calcium carbonate can enhance aluminium absorption from aluminium hydroxide in patients with impaired renal function.
    Lin JL; Leu ML
    Nephrol Dial Transplant; 1996 Sep; 11(9):1891-3. PubMed ID: 8918652
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antacid action of the aluminum cation: comparison of the in vitro effect of hydroxide and phosphate in open and closed systems].
    Vatier J; Lionnet F; Vitre MT
    Gastroenterol Clin Biol; 1987 Nov; 11(11):758-63. PubMed ID: 3428519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of aluminium overload in end-stage renal failure patients.
    Nephrol Dial Transplant; 1993; 8 Suppl 1():1-4. PubMed ID: 8389013
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dialysis encephalopathy in chronic renal failure].
    Markiewicz K; Bubiński R
    Pol Tyg Lek; 1980 Jul; 35(30):1159-62. PubMed ID: 7001402
    [No Abstract]   [Full Text] [Related]  

  • 19. Aluminum-free oral phosphate binder.
    Schneider H; Kulbe KD; Weber H; Streicher E
    Clin Nephrol; 1985; 24 Suppl 1():S98-102. PubMed ID: 3842107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of aluminum intoxication in chronic renal failure.
    Simon P; Allain P; Ang KS; Cam G; Mauras Y
    Adv Nephrol Necker Hosp; 1985; 14():439-78. PubMed ID: 3919543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.